Becker David Paul 4
4 · Adams Respiratory Therapeutics, Inc. · Filed Jan 30, 2007
Insider Transaction Report
Form 4
Becker David Paul
EVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2007-01-29$44.49/sh−100$4,449→ 7,132 total - Sale
Common Stock
2007-01-29$44.32/sh−60$2,659→ 12,135 total - Sale
Common Stock
2007-01-29$44.43/sh−300$13,329→ 7,782 total - Sale
Common Stock
2007-01-29$44.33/sh−50$2,217→ 12,085 total - Exercise/Conversion
Common Stock
2007-01-29$1.42/sh+12,285$17,445→ 12,285 total - Sale
Common Stock
2007-01-29$44.31/sh−90$3,988→ 12,195 total - Sale
Common Stock
2007-01-29$44.39/sh−439$19,487→ 8,494 total - Sale
Common Stock
2007-01-29$44.46/sh−500$22,230→ 7,282 total - Sale
Common Stock
2007-01-29$44.55/sh−150$6,683→ 5,654 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-01-29−12,285→ 24,570 totalExercise: $1.42Exp: 2014-01-24→ Common Stock (12,285 underlying) - Sale
Common Stock
2007-01-29$44.41/sh−97$4,308→ 8,082 total - Sale
Common Stock
2007-01-29$44.50/sh−401$17,845→ 6,731 total - Sale
Common Stock
2007-01-29$44.35/sh−550$24,393→ 11,535 total - Sale
Common Stock
2007-01-29$44.38/sh−2,502$111,039→ 8,933 total - Sale
Common Stock
2007-01-29$44.40/sh−315$13,986→ 8,179 total - Sale
Common Stock
2007-01-29$44.51/sh−601$26,751→ 6,130 total - Sale
Common Stock
2007-01-29$44.52/sh−276$12,288→ 5,854 total
Footnotes (2)
- [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting perosn on December 15, 2005.
- [F2]The options vest in five equal annual installments, beginning on January 26, 2005.